Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biosignatures for Lurasidone Response in Bipolar Depression
NCT02239094Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lurasidone in bipolar disorder (BD), sponsored by New York State Psychiatric Institute. Primary endpoint: Montgomery-Asberg Rating Scale for Depression at Week 8. Started Jan 2015; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02239094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02239094.